The following story is an article written by a member of the global bleeding disorders community to the World Federation of Hemophilia (WFH). In this article, Lexzar Gabriel Gador from the Philippines shares his story.
My name is Lexzar Gabriel Gador, and I was born in the Philippines. At age one, I was diagnosed with Hemophilia A. Growing up, I struggled to keep up with kids my age, and I was often a spectator when they engaged in activities that were beyond my physical capacity. Although I did well in academics, I believe I missed out on a lot of things during my childhood, particularly socially, which, perhaps, is why I’m introverted.
Now, at 21, I’m very grateful to those who make the humanitarian efforts of the World Federation of Hemophilia (WFH) possible. For years now, I’ve been living in relative comfort and happiness, thanks to the WFH Humanitarian Aid Program.
For the past few months, I’ve been undergoing prophylactic treatment and physical therapy, enabled by the factor concentrate donations our local organization here in Davao City has been receiving from the WFH. My physical condition is slowly, but steadily improving, and I hope that in the near future, I’ll be well enough to be of service to other people with bleeding disorders. I also hope to be a productive member of society.
Once again, to everyone behind the WFH, including the volunteers and health professionals who provide assistance to people suffering from hemophilia: THANK YOU!
About the WFH Humanitarian Aid Program
The expanded WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi Genzyme and Sobi, our Visionary Contributors; Grifols, CSL Behring, GC Pharma, our Corporate partners; and Roche and Bayer, our newest donors. To learn more about the WFH Humanitarian Aid Program, visit www.treatmentforall.org